SCHEMBL20222579

SCHEMBL20222579

c1ccc(-c2cc(-c3ccc4c(c3)-c3ccc5ccccc5c3Sc3ccccc3-c3ccccc3-c3ccccc3-4)nc(-c3ccc(-c4cccnc4)cc3)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 1/20 0.41
▸ CYP11B1 P15538 3/20 0.38
▸ CYP19A1 P11511 2/20 0.38
▸ CYP11B2 P19099 2/20 0.38
▸ CYP17A1 P05093 1/20 0.38
▸ ALDH1A1 P00352 5/20 0.36
▸ MAPT P10636 4/20 0.36
▸ HPGD P15428 4/20 0.36
▸ KDM4E B2RXH2 4/20 0.36
▸ RAB9A P51151 3/20 0.36
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ USP1 O94782 3/20 0.36
▸ WDR48 Q8TAF3 3/20 0.36
▸ NPC1 O15118 2/20 0.35
▸ TP53 P04637 2/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ MEN1 O00255 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ CYP2C9 P11712 2/20 0.35
▸ GLA P06280 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20222688 1.00 DHODH (0.41) DHODHCYP11B1CYP19A1CYP11B2CYP17A1
SCHEMBL20222818 0.97 DHODH (0.42) DHODHCYP11B1CYP19A1CYP11B2CYP17A1
SCHEMBL20222676 0.96 CYP19A1 (0.40) DHODHCYP11B1CYP19A1CYP11B2CYP17A1
SCHEMBL20222686 0.93 CYP11B1 (0.40) DHODHCYP11B1CYP19A1CYP11B2CYP17A1
SCHEMBL20222581 0.92 CYP19A1 (0.36) DHODHCYP11B1CYP19A1CYP11B2CYP17A1
SCHEMBL20845017 0.91 DHODH (0.38) DHODHCYP11B1CYP19A1CYP11B2CYP17A1
SCHEMBL20845247 0.91 DHODH (0.38) DHODHCYP11B1CYP19A1CYP11B2CYP17A1
SCHEMBL20222687 0.91 HPGD (0.40) ALDH1A1MAPTHPGDKDM4ESMN1; SMN2
SCHEMBL20222681 0.91 DHODH (0.37) DHODHCYP11B1CYP19A1CYP11B2CYP17A1
SCHEMBL20222820 0.90 DHODH (0.37) DHODHCYP11B1CYP19A1CYP11B2CYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10693077-B2 Compound and organic electronic device using the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2020-06-23 — — US disclosed
US-20180155312-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2018-06-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10693077-B2 Compound and organic electronic device using the same SOD1, SCO2, RCOR3 DHODH 1874/4885CYP11B1 592/4885CYP19A1 485/4885
US-20180155312-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME SOD1, SCO2, RCOR3 DHODH 1874/4885CYP11B1 592/4885CYP19A1 485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback